MetaCap

Milestone Scientific Inc. (MLSS)

NYSE: MLSSHealth CareIndustrial SpecialtiesUSD

0.24-0.002 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MLSS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$21.75M
EPS (TTM)
-$0.04
52-week range
0.22 – 0.58
Day range
0.231 – 0.2523
Volume / Avg
108.80K / 100.50K
Beta
—

52-week range

$0.22$0.58

MLSS stock today

Shares of Milestone Scientific (MLSS) finished lower on Nov 20 at $0.24, a drop of 0.83% or $0.002 per share, versus the S&P 500's 3.70% decline. Shares are 58.6% below their 52-week high of $0.58, set on Aug 13, 2026 and 9.1% above the 52-week low of $0.22, near the bottom of the past year's range. MLSS is down 11.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 20.0%.

Milestone Scientific has posted a net loss over the last twelve months (EPS of -$0.04), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Milestone Scientific

Company profile

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names.

Industry
Industrial Specialties
CEO
Mr. Eric C. Hines
Headquarters
Roseland, NJ
Employees
15
IPO year
2015

Financial highlights

Full financials

In fiscal 2025, Milestone Scientific generated $9.0 million in revenue, up 4.0% from fiscal 2024. Milestone Scientific reported a net loss of $5.7 million, compared with a loss of $4.7 million a year earlier. Gross margin was 71.4% (down from 74.6%) and operating margin -63.5%.

Milestone Scientific annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$8.97M$8.63M$9.83M$8.81M$10.30M
Growth+3.99%-12.19%+11.60%-14.54%+89.52%
Net income$-5.72M$-4.71M$-6.93M$-8.71M$-6.82M
EPS (diluted)$-0.07$-0.06——$-0.10

Analyst forecast

Forecast

Consensus (2 analysts)

none

Avg. price target

$1.25+420.83%

  • Strong buy 1
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $1.00High $1.50

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$-0.01 vs —

MLSS news

All MLSS news

Milestone Scientific peers

Health Care sector
MLSS peer companies
CompanyPrice% ChgMarket capCompare
TLIHTen-League International Holdings Limited5.79+0.70%$17.03Mvs MLSS
MYOMyomo Inc.0.811-3.45%$32.52Mvs MLSS
CUPRCuprina Holdings (Cayman) Limited Class A1.41-6.00%$10.79Mvs MLSS
HSCSHeartSciences Inc.1.81-10.84%$10.42Mvs MLSS
OPHICollPlant Biotechnologies Ltd3.13-2.49%$9.63Mvs MLSS
FGIFGI Industries Ltd.4.90-6.84%$9.46Mvs MLSS
MAMOMassimo Group0.8405+3.40%$35.00Mvs MLSS
LFWDLifeward Ltd.2.80-5.30%$7.96Mvs MLSS

Indexes, lists and sector

Milestone Scientific stock FAQ

What is Milestone Scientific's stock price today?

MLSS last traded at $0.24 as of Nov 20, 4:00 PM EST, down 0.83% on the day. Prices are delayed at least 15 minutes.

Does Milestone Scientific pay a dividend?

No. Milestone Scientific does not currently pay a regular cash dividend.

Who is Milestone Scientific's CEO?

Mr. Eric C. Hines is the chief executive officer of Milestone Scientific Inc., which has about 15 employees.

Has MLSS ever split its stock?

Yes. The most recent MLSS stock split was a 1-for-3 split on Jan 14, 2004.

What is the MLSS 52-week high?

The 52-week high for MLSS is $0.58 and the 52-week low is $0.22. The stock is currently 58.6% below its high.

Compare MLSS